WallStreetZenWallStreetZen
Analyst Ranking
Bottom 11%
#4057 out of 4529 analysts
Average Return
-16.48%
Win Rate
20%2 out of 10
Risk vs Reward
Poor
Good

Carl Byrnes's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Brainsway LtdBWAY
+133.50%$2.00$4.67
2022-11-17 -
2023-11-16
Buy
Gw Pharmaceuticals PLCGWPH
+123.25%$97.65$218.00
2020-04-08 -
2021-04-08
Buy

Carl Byrnes Analyst Color

Get additional color on Carl Byrnes's coverage of popular stocks

Carl Byrnes's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Amarin Corp PLCAMRN
1Hold$1.25+40.29%Maintains
8 months ago
Cardio Diagnostics Holdings IncCDIO
1Buy$8.00+463.38%Initiates Coverage On
10 months ago
Polarityte IncPTEIQ
1Buy$1.00N/AMaintains
a year ago
Brainsway LtdBWAY
1Buy$5.00N/AMaintains
a year ago
Vtv Therapeutics IncVTVT
2Buy$80.00N/AMaintains
2 years ago
Nabriva Therapeutics PLCNBRVF
1Buy$50.00N/AMaintains
2 years ago
Flexion Therapeutics IncFLXN
1HoldN/AN/ADowngrades
2 years ago
Adamas Pharmaceuticals IncADMS
1Hold$8.50N/ADowngrades
2 years ago
Skylight Health Group IncSLHGF
1Buy$9.00N/AInitiates Coverage On
2 years ago
Mimedx Group IncMDXG
1Buy$23.00N/AInitiates Coverage On
3 years ago
Esperion Therapeutics IncESPR
4Hold$24.00N/AMaintains
3 years ago
Gw Pharmaceuticals PLCGWPH
1Buy$128.00N/AInitiates Coverage On
4 years ago
Aytu Biopharma IncAYTU
1Buy$2,000.00N/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.